We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

A Caffeine and Theacrine Combination Enhances Cognitive Performance in Tactical Personnel Under Physical Fatigue

MedXY Editorial Team•Oct 5, 2025•Clinical Updates
caffeinecognitive performancefatigue

Introduction

Optimizing human performance during stressful physical and cognitive conditions remains critical for high-stakes military operations. Tactical personnel often face intense environments that can induce cognitive fatigue, compromising decision-making and operational effectiveness. While caffeine is globally recognized as the most widely consumed psychoactive substance used to enhance alertness and cognitive function, its common side effects—such as anxiousness, micro-saccades (small, involuntary eye movements), and irritability—may negatively impact performance in tactical settings. Therefore, alternative or adjunctive interventions are necessary to mitigate these drawbacks while enhancing cognitive resilience.

Theacrine, a purine alkaloid structurally related to caffeine but with a notably longer half-life and lower potential for habituation and side effects, is proposed as a promising caffeine alternative or complement. This alkaloid potentially offers sustained cognitive benefits with fewer adverse effects, making it attractive for enhancing cognitive-behavioral performance under fatigue.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Patient Perspectives on Prolactinoma in Females: Insights from the Dutch Cohort StudiesA large Dutch cohort study reveals fatigue and cognitive impairment as predominant symptoms in females with prolactinoma, with active disease linked to higher psychological burden despite dopamine agonist treatment.Sep 1, 2026Long-Term Fatigue in Differentiated Thyroid Cancer Survivors: Early Predictors and the Non-Impact of Thyrotropin SuppressionA nationwide prospective study identifies early fatigue and poor mental health as key predictors of long-term fatigue in differentiated thyroid cancer patients, while thyrotropin suppression shows no association with fatigue.Aug 21, 2026Decoding Sleep’s Role in Cognitive Health and Dementia Risk: Insights from the Sleep and Dementia ConsortiumThis study identifies distinct sleep patterns linked to cognitive performance but finds no significant direct association with dementia risk, highlighting the complexity of sleep-cognition relationships in aging populations.Jul 31, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Fatigue After Thyroidectomy: What Patients Actually Experience
A qualitative study found that fatigue after thyroidectomy is common, disruptive, and often unexpected. Patients described major impacts on work and daily life, and many wanted surgeons to warn them about it before surgery.
May 20, 2026
Fluvoxamine Shows Promise for Treating Long COVID Fatigue: Results from Adaptive Randomized TrialA randomized trial of 399 adults with long COVID fatigue found that fluvoxamine significantly reduced fatigue severity at 60 and 90 days compared to placebo, while metformin showed no benefit. The study represents a potential breakthrough iApr 3, 2026
Moderate Caffeinated Coffee and Tea Intake Linked to 18% Lower Dementia Risk in Decades-Long StudyA prospective study of over 130,000 adults reveals that consuming 2-3 cups of caffeinated coffee or 1-2 cups of tea daily significantly reduces dementia risk and cognitive decline, whereas decaffeinated coffee shows no protective effect.Feb 10, 2026